In Brief: Roche/Organon Teknika
This article was originally published in The Gray Sheet
Executive Summary
Roche/Organon Teknika: Ink worldwide settlement agreement to end patent litigation pending in several countries including the U.S. related to nucleic acid amplification technology. Hoffmann-La Roche first brought suit against Teknika in 1995 in The Netherlands alleging that Teknika's NASBA RNA transcription-based gene amplification system infringed Roche patents covering its PCR polymerase chain reaction gene amplification technology. Since the initial suit was filed, Dutch and German courts have ruled in Teknika's favor in the disputes ("The Gray Sheet" Sept. 16, 1996, In Brief). Terms of the settlement are not being disclosed...
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.